Magellan Health (MGLN) Tops Q4 EPS by 66c

April 30, 2021 6:43 AM EDT

Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.33, $0.66 better than the analyst estimate of $0.67. Revenue for the quarter came in at $1.16 million versus the consensus estimate of $1.14 million.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings